Optimization of an Experimental Vaccine To Prevent Escherichia

Optimization of an Experimental Vaccine to Prevent Escherichia coli Urinary Tract Infection

Intranasal COVID-19 vaccines: From bench to bed - eBioMedicine

Full article: Immunoinformatics aided designing of a next generation poly-epitope vaccine against uropathogenic Escherichia coli to combat urinary tract infections

Vaccine-induced COVID-19 mimicry syndrome

Strategies for efficient production of recombinant proteins in Escherichia coli: alleviating the host burden and enhancing protein activity, Microbial Cell Factories

Vaccines, Free Full-Text

Nanovaccines to combat virus‐related diseases - Wu - 2023 - WIREs Nanomedicine and Nanobiotechnology - Wiley Online Library

Current status of experimental models for the study of malaria, Parasitology

Vaccines, Free Full-Text

Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines

Microorganisms, Free Full-Text

Tweak to Treat: Reprograming Bacteria for Cancer Treatment: Trends in Cancer

PDF) Optimization of an Experimental Vaccine To Prevent Escherichia coli Urinary Tract Infection